{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:22:19Z","timestamp":1783938139195,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.contraception.2018.01.010","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T13:03:57Z","timestamp":1519650237000},"page":"478-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["The relationship between progestin hormonal contraception and depression: a systematic review"],"prefix":"10.1016","volume":"97","author":[{"given":"Brett L.","family":"Worly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar L.","family":"Gur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7660-639X","authenticated-orcid":false,"given":"Jonathan","family":"Schaffir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2018.01.010_bb0005","unstructured":"Bakalar N. \u201cContraceptives tied to depression risk.\u201d The New York Times. Published 9\/30\/2016."},{"key":"10.1016\/j.contraception.2018.01.010_bb0010","unstructured":"Mettler, K. \u201cIt's not in your head: striking new study links birth control to depression.\u201d The Washington Post. Published 10\/5\/2016."},{"issue":"4","key":"10.1016\/j.contraception.2018.01.010_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.1996.03540040037030","article-title":"Cross-national epidemiology of major depression and bipolar disorder","volume":"276","author":"Weissman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2018.01.010_bb0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.euroneuro.2006.02.006","article-title":"The progesterone metabolite allopregnanolone potentiates GABA(a) receptor-mediated inhibition of 5-HT neuronal activity","volume":"17","author":"Kaura","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.contraception.2018.01.010_bb0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbr.2012.06.034","article-title":"A rodent model of premenstrual dysphoria: progesterone withdrawal induces depression-like behavior that is differentially sensitive to classes of antidepressants","volume":"234","author":"Li","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.contraception.2018.01.010_bb0030","series-title":"Clinical data summary","article-title":"The Upjohn company, NDA 20-246. Application summary","year":"1992"},{"key":"10.1016\/j.contraception.2018.01.010_bb0035","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Mohrer","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2018.01.010_bb0040","author":"US Preventive Services Task Force"},{"key":"10.1016\/j.contraception.2018.01.010_bb0045","series-title":"Cochrane handbook for systematic reviews of interventions: Cochrane book series","year":"2008"},{"key":"10.1016\/j.contraception.2018.01.010_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(98)00024-9","article-title":"Depressive symptoms and depo-Provera","volume":"57","author":"Westhoff","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0055","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2008.04.048","article-title":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microgram oral contraceptive pills","volume":"199","author":"Berenson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.01.010_bb0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(00)00122-0","article-title":"Depressive symptoms in users and non-users of depot medroxyprogesterone acetate","volume":"61","author":"Civic","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0010-7824(95)00100-O","article-title":"Depression in users of depo-medroxyprogesterone acetate","volume":"51","author":"Westhoff","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0029-7844(96)00194-9","article-title":"Experiences of injectable contraceptive users in an urban setting","volume":"88","author":"Sanghi-Haghpeykar","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2018.01.010_bb0075","first-page":"209","article-title":"Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation","volume":"56","author":"Paul","year":"1997"},{"key":"10.1016\/j.contraception.2018.01.010_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0010-7824(98)00022-5","article-title":"Depressive symptoms and Norplant contraceptive implants","volume":"57","author":"Westhoff","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/00016349509024406","article-title":"Perceptions and satisfaction among Norplant users in Finland","volume":"74","author":"Sihvo","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2018.01.010_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0010-7824(98)00112-7","article-title":"Contraception with two levonorgestrel rod implants","volume":"58","author":"Sivin","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1054-139X(94)00029-E","article-title":"Adolescents and Norplant: preliminary findings of side effects","volume":"16","author":"Kozlowski","year":"1995","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.contraception.2018.01.010_bb0100","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2009.03.021","article-title":"Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users","volume":"80","author":"Wong","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/13625187.2013.853034","article-title":"A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system","volume":"19","author":"Weisberg","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.01.010_bb0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.contraception.2009.04.003","article-title":"Insertion and 3-year follow-up experience of 372 etonorgestrel subdermal contraceptive implants by family physicians in Granada, Spain","volume":"80","author":"Arribas-Mir","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.contraception.2009.05.132","article-title":"Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia","volume":"80","author":"Harvey","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0120","first-page":"734","article-title":"Australian women's experiences of the subdermal implant: a qualitative perspective","volume":"45","author":"Inoue","year":"2016","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.contraception.2018.01.010_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0025-6196(11)63613-6","article-title":"Levonorgestrel contraceptive implants in female patients 14 to 21 years old","volume":"73","author":"Suman","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.contraception.2018.01.010_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF03004171","article-title":"Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system","volume":"14","author":"Elovainio","year":"2007","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.contraception.2018.01.010_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00404-014-3237-1","article-title":"Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study","volume":"290","author":"Pekin","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2018.01.010_bb0140","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/der269","article-title":"Hormonal contraception and mental health: results of a population-based survey","volume":"26","author":"Toffol","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2018.01.010_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-7824(82)90092-0","article-title":"Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a Nova-T-copper device","volume":"25","author":"Nilssson","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0150","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","article-title":"Association of hormonal contraception with depression","volume":"73","author":"Skovlund","year":"2016","journal-title":"JAMA Psychiat"},{"key":"10.1016\/j.contraception.2018.01.010_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(95)00226-X","article-title":"The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestin-only methods","volume":"52","author":"Graham","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0160","first-page":"1","article-title":"The effect of depot medroxyprogesterone acetate on postnatal depression: a randomized controlled trial","author":"Singata-Madliki","year":"2016","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2018.01.010_bb0165","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1471-0528.1998.tb09940.x","article-title":"A double blind randomized placebo controlled trial of postnatal of norethisterone enanthate: the effect on postnatal depression and serum hormones","volume":"105","author":"Lawrie","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2018.01.010_bb0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.contraception.2010.03.004","article-title":"Effect of depot medroxyprogesterone acetate on postpartum depression","volume":"82","author":"Tsai","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2018.01.010_bb0175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1054-139X(99)00091-9","article-title":"The timing of Norplant insertion and postpartum depression in teenagers","volume":"26","author":"Stevens-Simon","year":"2000","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.contraception.2018.01.010_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1083-3188(01)00074-2","article-title":"Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study","volume":"14","author":"Gupta","year":"2001","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.contraception.2018.01.010_bb0185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.94.5.687","article-title":"A prospective study of adolescents who chose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (depo-Provera), or the combined-oral contraceptive pill as contraception","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.contraception.2018.01.010_bb0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1054-139X(95)00094-9","article-title":"Depo-Provera in adolescents: effects of early second injection or prior oral contraception","volume":"16","author":"Harel","year":"1995","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.contraception.2018.01.010_bb0195","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.psyneuen.2007.05.013","article-title":"Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression","volume":"32","author":"Young","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.contraception.2018.01.010_bb0200","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2015"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418300325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782418300325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T22:01:44Z","timestamp":1660514504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782418300325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0010782418300325"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2018.01.010","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between progestin hormonal contraception and depression: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2018.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}